SUMMARY Spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats were used to investigate the adaptive biochemical changes in the myocardium in response to chronic afterload. Ouabain-inhibited Na + , K + -adenosine triphosphatase (ATPase) activity was decreased by 40% in myocardium of SHR compared with that from WKY, which may lead to increased intracellular Ca 2+ through Na + -Ca 2+ exchange. Similarly, a,-adrenergic receptor density, estimated by [ 3 H]prazosin binding, was decreased by 42% in myocardial membranes of SHR, while the affinity for the agonist and the antagonist was not altered. In contrast, the number of Ca 2+ channels estimated by [ 3 H]nitrendipine binding was increased by 45% in myocardial membranes of SHR, while the affinity was comparable between SHR and WKY. These differences between WKY and SHR in the membrane properties were not due to differential contamination of plasma membranes because the activities of other putative plasma membrane marker enzymes were comparable between WKY and SHR. There were no differences between WKY and SHR in the myosin ATPase activity estimated using myofibrils, actomyosin, and myosin. These results suggest that specific alterations have occurred in the plasma membrane properties of myocardium of SHR that result in altered intracellular Ca 2+ metabolism. These alterations may have an important bearing on excitation-contraction coupling in myocardium of SHR. (Hypertension 8: 583-591, 1986) KEYWORDS * spontaneously hypertensive rats • plasma membranes • Na + ,K + -ATPase * a,-adrenergic receptors • Ca 2+ channels • myosin ATPase T HE established phase of arterial hypertension in spontaneously hypertensive rats (SHR) is accompanied by cardiac hypertrophy, subnormal cardiac output, and an elevated total peripheral resistance.
T HE established phase of arterial hypertension in spontaneously hypertensive rats (SHR) is accompanied by cardiac hypertrophy, subnormal cardiac output, and an elevated total peripheral resistance. 1 However, the molecular mechanisms of subnormal cardiac output are not known. In cardiac muscle, the increased level of cytosolic Ca 2+ during excitation-contraction coupling is mediated by Ca 2+ release from sarcoplasmic reticulum, which is triggered by an influx of Ca 2+ across the plasma membrane 2 or is due to inositol 1,4,5-trisphosphate (IP 3 )-mediated Ca 2+ release. 3 Thus, this trigger Ca 2+ enters the cell during each systole and is pumped out during each diastole. Thus, there are three potential mecha-nisms for increasing cytosolic Ca 2+ concentration 2 : 1) the slow, inward Ca 2+ current through potential dependent Ca 2+ channels, 2) Na + -Ca 2+ exchange across sarcolemma, and 3) Ca 2+ released from the sarcoplasmic reticulum. Any of these mechanisms may be altered in myocardium of SHR. To test whether the slow Ca 2+ channels are altered in myocardium of SHR, we studied the [ 3 H]nitrendipine binding, which has been shown to bind specifically to myocardial Ca 2+ channels with high affinity. 4 " 6 Several investigators have shown a close quantitative relationship among the degree of Na + -K + pump inhibition, increases in the exchangeable cellular Na + and Ca 2+ content, and positive inotropic response. 7 " 9 Therefore, decreased Na + ,K + -adenosine triphosphatase (ATPase) activity in hypertension could lead to increased contraction in the cardiovascular tissues, as suggested by Overbeck 10 and Haddy et al." Such a decrease has been demonstrated in the plasma membranes isolated from myocardium of SHR as compared with that in Wistar-Kyoto rats (WKY).
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HYPERTENSION VOL 8, No 7, JULY 1986 sion. 13 One of the most prominent actions of catecholamines on the heart is their ability to increase the influx of Ca 2+ into myocardial cells. The positive inotropic and chronotropic responses to catecholamines usually have been assumed to be due to the activation of /3-adrenergic receptors. However, phenylephrine and other a-adrenergic receptor agonists have been shown to cause positive inotropy in the heart, an action that can be blocked by phentolamine.
14 " 16 It is, therefore, reasonable to assume that the a-adrenergic receptor mediated mechanism in hypertrophied hearts from SHR may be considerably different from that occurring in control hearts. Thus, it was logical to investigate whether changes in the number and affinity of a,-adrenergic receptors have occurred in the myocardium of SHR.
In certain models of cardiac hypertrophy the reduced cardiac function is associated with a decrease in contractile protein ATPase activity, and this decrease has been attributed to a shift in myosin isoenzyme from V, to V 3 . 17 These changes have important functional implications because the shortening velocity of cardiac muscle and cross-bridge cycling have been shown to be correlated with myosin ATPase activity 17 ' 18 and myosin isoenzyme composition." To understand the adaptive biochemical changes in response to chronic afterload, we have investigated plasma membrane properties with respect to Na + ,K + -ATPase activity, the number of Ca 2+ channels and a,-adrenergic receptors and contractile protein ATPase activity in young adult SHR with moderate left ventricular hypertrophy.
Materials and Methods
Age-matched (16-week-old), male SHR and WKY were used (70 and 80 animals, respectively; Taconic Farms, Germantown, NY, USA). All rats were weighed biweekly, and blood pressure was measured by the tail-cuff method in conscious rats. The rats were maintained under identical conditions and given Purina rodent laboratory chow (St. Louis, MO, USA) and tap water ad libitum.
Drugs
The The rats were killed by direct heart puncture while under ether anesthesia, and their hearts were removed. The coronary circulation then was flushed through the aorta with physiological salt solution and the ventricles were excised, blotted on filter paper, and weighed to calculate ventricle weight/body weight ratio as an index of cardiac hypertrophy. The right ventricle then was removed, and the left ventricle along with septum was ground in liquid nitrogen and stored in individual vials at -100°C for estimation of contractile protein ATPase activity. Myofibrils, free of mitochrondria, sarcolemma, and sarcoplasmic reticulum, were prepared from individual left ventricles, essentially by the method of Solaro et al. 20 The sodium dodecyl sulfate polyacrylamide gels of myofibrils for different groups did not show any differences in the protein profiles. Actomyosin was extracted from the myofibrils. Myosin was prepared from left ventricles pooled from two to three animals by the method of Offer et al. 21 Purity of myosin was checked by sodium dodecyl sulfate gel electrophoresis. Myosin was free of contamination from actin, troponin, and tropomyosin in all preparations. The 280:260 ratio was between 1.45 and 1.55 for all batches of myosin prepared. Myosin was dialyzed against 0.5 M KC1, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 0.1 mM dithiothreitol, 1 mM NaN 3 , and 10 mM tris(hydroxymethyl)aminomethane (Tris) HC1, pH 7.6, for 36 hours before use. Actin was purified from rabbit skeletal muscle acetone powder by the method of Spudick and Watt. 22 
ATPase Assay
All contractile protein ATPase activities were estimated at 30°C. Myofibrillar ATPase activity was determined in 40 100 fig myosin) . Actin-activated myosin ATPase activity was assayed in 50 mM imidazole HC1 (pH 7.0), 0.1 mM dithiothreitol, 1.5 mM ATP, 2.0 mM MgCl 2 , 1 mM NaN 3 , 50 mM KC1, and 26 /xM skeletal muscle actin. Reactions were started by adding ATP, and reaction volume was 1 ml in all ATPase assays. The inorganic phosphate (P,) liberation was measured by the method of Fiske and Subbarow.
Protein concentration was determined by the method of Bradford 24 using bovine serum albumin as the standard.
Preparation of Plasma Membranes
Cardiac plasma membranes were prepared identically for each group of rats. All steps were performed at 4°C. Rats were killed by direct heart puncture while under ether anesthesia, and atria, connective tissue, and major vessels were removed. Individual hearts were weighed, and 10 to 15 hearts were then combined for each preparation. The tissue was homogenized in 10 volumes of homogenizing buffer (approximately 140-160 ml) containing 20 mM Tris maleate (pH 6.8), 0.25 M sucrose, 1 mM dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride with a Polytron homogenizer (Model PT 10; Brinkmann Instruments, Westbury, NY, USA) at half-maximum speed for three 10-second bursts alternated with 1-minute rest intervals. The resulting homogenate was centrifuged at 2000 rpm for 10 minutes in a Sorvall SS-34 rotor (Norwalk, CT, USA), and the supernatant was then centrifuged at 8500 rpm for 20 minutes in a Sorvall SS-34 rotor. The supernatant from this step was centrifuged at 30,000 rpm for 30 minutes in a Beckman 35 rotor (Palo Alto, CA, USA). The resulting pellet was designated as microsomes and extracted for 30 minutes at 0°C with 50 ml of 0.6 M KC1 in homogenizing buffer to remove contractile proteins. The microsomes were centrifuged at 30,000 rpm for 30 minutes in a Beckman 35 rotor. A discontinuous gradient, consisting of 7 ml each of 10%, 28%, 33%, 37%, and 45% (wt/wt) sucrose, was employed for the preparation of plasma membranes from washed microsomes. All sucrose solutions contained 20 mM Tris maleate (pH 6.8), 0.6 M KC1, 1 mM dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride. The extracted microsomes were suspended in 37% sucrose (3 mg/ml), and 7 ml of this suspension was layered over a 5-ml cushion of 45% sucrose in each gradient tube. The gradients were centrifuged overnight at 27,000 rpm using a Beckman SW-27 rotor. The accumulated membranes at the interface of the 10 to 28% sucrose were collected, the concentration was adjusted to 10% sucrose by adding a buffer containing 20 mM Tris maleate (pH 6.8) and 1 mM dithiothreitol, and the solution then was centrifuged at 30,000 rpm for 30 minutes in a Beckman Ti 50.2 rotor. The pellet was washed once with a buffer containing 20 mM Tris maleate (pH 6.8), 1 mM dithiothreitol, and 0.25 M sucrose and dispersed in the same buffer at a concentration of 1 mg/ml. Membranes were assayed for enzyme activity either immediately or following storage at -7 0°C for up to 3 weeks. The incubation time was 5 minutes at 37 °C. The reaction was terminated by adding 5 ml of malachite green reagent, and the P, was determined. 23 Protein sample blanks were necessary for these assays because the homogenate gives color with malachite green. This color is probably due to the large quantities of phosphate liberated from the tissue high-energy phosphates during hydrolysis with the 1 N HC1 present in the malachite green reagent. Enzyme activity was measured at 37°C for 1 to 10 minutes. Reactions were stopped by adding 1 ml ice-cold reagent IV 26 containing 10% (wt/vol) trichloroacetic acid instead of HC1 and immediately placing the tubes in ice. The inorganic phosphate production was measured according to the method of Ottolenghi. Binding was terminated in all experiments by the addition of 5 ml of ice-cold 50 mM Tris HC1 (pH 7.4) and 10 mM MgCl 2 , followed by rapid filtration through Whatman GF/C filters. The filters were then washed three times with 5 ml of wash buffer, dried at 60 °C for 1 hour, and counted in 10 ml of Beckman HP scintillant. All results are expressed as means of triplicate determinations after subtracting nonspecific binding in the presence of 0.1 /nM unlabeled prazosin. Table 1 shows the blood pressure, body weight, and heart weight/body weight ratio of SHR and WKY. The body weight of SHR was significantly less than that of WKY, while their heart weight/body weight ratio and blood pressure were significantly greater.
The protein yield of plasma membrane vesicles (mg/g, ventricular weight/tissue weight) was comparable between WKY and SHR. The putative marker enzyme activities of 5'-nucleotidase, phosphodiesterase I, alkaline phosphatase, and ouabain-inhibited Na + ,K + -ATPase were enriched 30-fold to 35-fold as compared with homogenates in both WKY and SHR (Figure 1) . Furthermore, no differences in the specific activity of 5'-nucleotidase, phosphodiesterase I, and alkaline phosphatase were observed between WKY and SHR.
The ouabain-sensitive Na + ,K + -ATPase activity was determined in homogenate as well as plasma membrane preparations of myocardium from SHR and WKY. In both homogenate and plasma membranes, the Na + ,K + -ATPase activity was significantly decreased in hearts of SHR as compared with those of WKY (see Figure 1) . The enzyme activity was reduced by 36% in the homogenate and 43% in the plasma (Figure 2 and Table  2 ). Similarly, the ligand affinity was also estimated by studying the inhibition of [ 3 H]prazosin using different concentrations of unlabeled prazosin and norepinephrine ( Figure 3) . The inhibition constant (K) values for inhibition of [ 3 H]prazosin-specific binding are given in Table 2 ; there were no differences between WKY and SHR in AT; values for prazosin and norepinephrine. These results indicate that the receptor density is decreased in SHR as compared with that in WKY, whereas a,-adrenergic receptor affinity is not altered in the myocardium of SHR.
[ Figure 2 ). The 50% inhibitory concentration (IC^ values were determined graphically (see Figure 3) . The K t values were calculated from the equation K t = IC 50 /( 1 + SIK a ), where S is the concentration of [ The protein yield of myofibrils, actomyosin, and myosin was comparable in SHR and WKY. Myofibrillar ATPase activity was determined at 10" 6 M free Ca 2+ , which was found to be suitable for maxi-
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10 " 10 1° 10"°0 myosin ( Figure 6 ). Similarly, Ca 2+ -stimulated actomyosin and myosin ATPase activities were not different between groups when assayed in the presence of 10 mM Ca 2+ and 500 mM K + (see Figure 6 ). Discussion The findings of this study reveal the following significant alterations in the myocardial membrane properties of SHR as compared with those of WKY: 1) ouabain-sensitive Na + ,K + -ATPase activity was decreased by 40%, 2) a,-adrenergic receptor density was decreased by 43%, and 3) Ca 2+ channel density was increased by 42%. On the other hand, the myosin ATPase activity of myofibrils, actomyosin, and purified myosin were comparable in WKY and SHR, which suggests that moderate compensatory cardiac hypertrophy is not associated with changes in myosin ATPase activity. These results are in agreement with the observations of Lauva and Sen, 27 who found no differences in the myosin isoenzyme distribution between WKY and SHR up to 24 weeks of age. However, studies in older rats (36-52 weeks of age) showed differences in the myosin isoenzyme pattern 28 ' w and a decrease in myofibrillar ATPase activity. 30 These data suggest that changes in myosin isoenzyme distribution and myosin ATPase activity in SHR appear after 8 to 9 months of age.
Our results also demonstrated that the ouabain-sensitive Na + ,K + -ATPase activity was decreased by 35 to 45% in both homogenates and purified plasma membranes of myocardium from SHR. The decrease in the Na + ,K + -ATPase activity in the plasma membranes of SHR myocardium does not appear to be due to differential contamination of sarcolemma with contractile proteins or other subcellular organelles for the following reasons: 1) the protein yield of plasma membranes (mg/g wet tissue weight) was comparable in WKY and SHR; 2) the activity of other putative plasma membrane marker enzymes (i.e., 5'-nucleotidase, phosphodiesterase I, and alkaline phosphatase) was comparable in both groups of membrane preparations; 3) through the mechanisms just discussed. These changes may represent compensatory mechanisms for left ventricular function and myocardial mechanics in young adult SHR to cope with the elevated peripheral resistance.
The number and affinity of [ 3 H]nitrendipine binding sites observed in this study in plasma membrane from WKY are comparable to those reported for rat and dog heart subcellular fractions. 4 "" 6 We also observed a significant increase in the number of [ 3 H]nitrendipine binding sites in myocardium from SHR as compared with that from WKY with no differences in its affinity. On the other hand, an earlier study found only a slight increase in the number of [ 3 H]nitrendipine binding sites in heart membranes from SHR as compared with those from WKY. 33 However, that study used a crude membrane fraction that may have been differentially contaminated with other subcellular organelles and contractile proteins, thus masking the differences between WKY and SHR. Moreover, the K i and B,,v alues reported in that study 35 differed significantly from our values as well as those reported for canine and rat myocardial subcellular fractions.
4~6
In the myocardium, transmembrane Ca 2+ influx during action potential is controlled by opening of the slow Ca 2+ channels on depolarization of the cell. The extent of slow-channel opening is also controlled by activation of cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase and the phosphorylation of protein at the phosphorylation-dependent gate. 36 The Ca 2+ influx through potential dependent slow channels is inhibited by Ca 2+ antagonists such as verapamil, nifedipine, and diltiazem. It seems likely that the phosphorylation-dependent opening of the slow Ca 2+ channels may be decreased in myocardium of SHR because hormone-stimulated adenylate cyclase activity 37 and cAMP-dependent protein kinase activity 38 have been shown to be decreased in the myocardium of SHR as compared with those in WKY. Therefore, the increase in [ 3 H]nitrendipine binding sites in myocardium from SHR may represent a compensatory mechanism to increase Ca 2+ influx during action potential.
In the present study, the a,-adrenergic receptor density was decreased by 42% in myocardium from SHR as compared with that in WKY. Similarly, a 35% decrease in [ 3 H]dihydroergocryptine binding has been reported in the myocardium of renal hypertensive rats as compared with normotensive control rats. 39 On the other hand, the affinity of a,-adrenergic receptors for both [ 3 H]prazosin and norepinephrine was comparable in WKY and SHR. The K d values of [ 3 H]prazosin binding calculated by Scatchard analysis (see Table 2 ) were comparable to those reported earlier 40 ; however, in our study, the number of binding sites in heart membranes from WKY was almost 10 times higher than those reported for Sprague-Dawley rat heart membranes. 40 These differences could be attributed to the use of highly purified plasma membranes in our study. The role of a,-adrenergic receptors in myocardial function is not clearly established, but recently it has been suggested that a,-adrenergic receptor stimulation may facilitate Ca 2+ influx across sarcolemma or increase Ca 2+ release from intracellular stores through Ca 2+ -dependent Ca 2+ release from sarcoplasmic reticulum, or do both (for review see Reference 14) . Considerable evidence has accumulated from various types of mammalian cells that stimulation of a,-adrenergic receptors mediates intracellular Ca 2+ release through the breakdown of membrane phosphatidylinositides and the release of inositol bis-phosphates and tris-phosphates. 41 " 43 Recently rP 3 has been shown to release Ca 2+ from a nonmitochondrial Ca 2+ pool. 41^43 Similarly, addition of IP 3 to the cardiac sarcoplasmic reticulum vesicles was also reported to induce Ca 2+ release. 3 Thus, a reduced number of a,-adrenergic receptors in the myocardium of SHR is likely to cause a decrease in Ca 2+ influx across sarcolemma or Ca 2+ release from the intracellular Ca 2+ pools during excitation-contraction coupling in response to a,-adrenergic receptor stimulation due to 1) a decrease in IP 3 production, 2) Ca 2+ -dependent Ca 2+ release, or 3) a decrease in the intracellular Ca 2+ storage capacity of sarcoplasmic reticulum. VOL 8, No 7, JULY 1986 There are three potential mechanisms for increasing cytosolic Ca 2+ concentration in cardiac muscle: 1) the slow inward Ca 2+ current regulated by membrane potential changes, a,-adrenergic receptor stimulation, and cAMP-dependent protein phosphorylation; 2) Na + -Ca 2+ exchange across sarcolemma, which can be regulated by alterations in Na + 2+ influx appear to be increased in the myocardium of young adult SHR. However, from these results it is not clear.whether these changes in the myocardium of SHR are associated with the development of hypertension or are inherited defects. It will be of interest to investigate these mechanisms in prehypertensive animals and after treatment of these animals with antihypertensive drugs to establish whether these changes are a consequence of the hypertensive process or represent a contributory cause. R V Sharma, C A Butters and R C Bhalla hypertensive rats.
Alterations in the plasma membrane properties of the myocardium of spontaneously
